Adherence to Tamoxifen Therapy Declines in Male Patients With Breast Cancer
A population-based study revealed risk factors for endocrine therapy discontinuation and medication nonadherence in men with breast cancer.
All articles by Jennifer Larson
Skin Cancer Risk Factors, Health Behaviors Differ Among Asian American Groups
Researchers identified cultural and practical differences among Asian American subgroups that should influence culturally aware counseling for these patients.
Potential of Bupropion for Loss of Sexual Desire in Female Cancer Survivors
Researchers sought to determine if bupriopion improved sexual desire, satisfaction, or fatigue interference with function in women cancer survivors.
5-Gene Risk Score Model Effectively Predicts Prognosis in Multiple Myeloma
Researchers sought to develop and validate a risk score model to predict prognosis for patients with multiple myeloma.
Excess Risk of CVD Low With Radiotherapy After Chemotherapy for Early-Stage Hodgkin Lymphoma
Researchers sought to determine the potential risk of cardiovascular mortality vs risk of disease recurrence in patients with early-stage HL receiving IFRT after ABVD.
Qualitative Study Sheds Light on Patient Trust in Shared Decision Making in MM Treatment
Researchers interviewed multiple myeloma patients to determine what factors influence their ability to participate in shared decision-making with their clinicians.
Algorithm Assesses Risk of Major Adverse Cardiovascular Events in TKI-Treated CML
Researchers sought to determine the accuracy of established tools in predicting the risk of cardiovascular events in patients with CML receiving TKIs.
Research Assessment Seeks Evidence to Guide Treatment of MPN With COVID-19
Investigators assessed studies for evidence to guide the management of MPN in patients with COVID-19.
Utilization Patterns Explain Nonadherence to Treatment for Multiple Myeloma, CML, Some Metastatic Cancers
A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
Pretreatment Found to Reduce Stages of Mohs Surgery for Basal Cell Carcinoma
A retrospective study evaluated the effect of 5% imiquimod prior to Mohs surgery in patients with basal cell carcinoma.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...